Alzamend Neuro Inc
For the period ended Jul 31, 2024. Filed Sep 11, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2024 · Filed Sep 11, 2024
ALZN$1.41-9.0%Stored close · as of Nov 6, 2026
Opening this filing…